CAS NO.:431579-34-9
MF: C152H252N44O42
MW: 3367.2
Purity: 99.00%
Appearance: White Powder
Grade: Pharmaceutical Grade
YK-11 offers the extreme muscle building properties of steroids without the nasty steroid side effects and is a fantastic solution for those who don't like to use steroids.
YK11 For Cutting
YK11 actually increases the ability to generate muscle so is often used within a bulking cycle but it can also help during cutting too. This is because it will only add lean mass, and not just bulk. Therefore, it can prevent the loss of muscle which can occur when calorific intake is slashed making it ideal for cutting cycles.
Although still in its infancy, the potential uses for YK11 on a bulking cycle are almost limitless. Early indications suggest that this could be the strongest SARMs to hit the market providing the greatest potential for adding sheer muscle.
The compound works by inhibiting the action of myostatin on the muscle which in turn allows for far superior muscle growth.
Taking a Moderate dose (4mg – 8mg per day, 2 to 4 capsules per day) of “YK-11” the user can expect to get a more Aesthetic Physique (Lean, Hard and Strong).
Taking a Large dose (18mg – 22mg per day, 9 to 11 capsules) of “YK-11” the user will experience Gaining More Muscle Tissue and maintaining Extreme Muscle Fullness (The “Pumped” Look) 24/7.
This is attributed to the abilities of “YK-11” inducing the muscle cells to produce more Follistatin (even more than DHT Steroids), which helps inhibit the production of Myostatin (Myostatin – limits muscle growth). This S.A.R.M. has the potential for being as good as Testosterone in term of Muscle Strengthening, but without the negative side effects.
Initial Research by Japanese Researcher, Yuichiro Kanno, in 2011 at Toho University, has shown that “YK-11” attaches itself to the androgen receptor and makes muscle cells produce more anabolic factors. He also discovered that “YK-11” induces the muscle cells to produce more Follistatin, which decreases Myostatin and increases Muscle Growth.
Name | NO. | Usage |
RAD140 | 1182367-47-0 | New generation for gaining mass and cutting edges |
Andarine(S4) | 401900-40-0 | partial agonist, intended mainly for treatment of benign prostatic hypertrophy |
MK-677 | 15972-10-0 |
A growth hormone secretagogue, treatment of obesity, a promising therapy for the treatment of frailty in the elderly |
LGD-4033 | 1165910-22-4 | pharmacological profile similar to that of enobosarm, Ostarine,MK-2866 |
GW1516 | 317318-70-0 | For obesity, diabetes, dyslipidemia and cardiovascular disease |
MK2866 | 841205-47-8 |
medical prescription for prevention of cachexia, atrophy, and sarcopenia and for Hormone or Testoserone Replacement Therapy. |
SR9009 | 1379686-30-2 |
under development at The Scripps Research Institute (TSRI), increases the level of metabolic activity in skeletal muscles of mice |
Aicar | 2627-69-2 |
acts by entering nucleoside pools, significantly increasing levels of adenosine during periods of ATP breakdown |
YK11 | 431579-34-9 | YK11: a SARM and myostatin inhibitor in one |
PRODUCT NAME | YK11 | |||
CAS no. | 1370003-76-1 | Quantity | 18.5kg | |
Storage | In an airtight container, protected from light. | |||
Items of analysis | Specification | Results | ||
Description | White to off-white powder | Complies | ||
1HNMR | Conforms to structure | Complies | ||
Residual on ignition | ≤0.5% | 0.08 | ||
Loss on drying | ≤2.0% | 0.72 | ||
Assay | ≥99.0% | 99.62 | ||
Conclusion | Conforms with enterprise standards |